Alnylam Pharmaceuticals | Zysk Brutto



Pre Tax Profit Zmiana Data
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD -175115000 2.32M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Incyte USD 234.19M 172.64M 2025-03
Ionis Pharmaceuticals USD -147000000 40M 2025-03
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Takeda JPY 26.41B 92.96B 2024-12
Tectonic Therapeutic USD -17716000 5.02M 2024-09
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Xencor USD -52626000 6.33M 2024-12



Alnylam Pharmaceuticals Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.